Medline pulls all electric home-care beds nationwide after fire and entrapment reports

Medline Industries, the Northfield, Illinois-based medical supply company whose products fill hospitals, nursing homes and living rooms across the country, is pulling its entire line of electric home-care hospital beds off the market, after months of regulatory warnings culminated in a company-wide withdrawal this month. The move affects beds used by hospice patients, people recovering from surgery and others with limited mobility in private homes and long-term-care facilities nationwide.

Medline notified providers and distributors in an urgent field safety notice on October 14 that it was voluntarily removing and discontinuing all of its brand homecare, bariatric and long-term-care beds, along with the hand-control pendants, side rails, mattresses and replacement parts sold with them, according to a summary of the notice published by the American Health Care Association and National Center for Assisted Living, a trade group that notified nursing homes and home-care providers of the action. The Food and Drug Administration lists the matter as a Class I recall, its most serious category, reserved for products that could cause serious injury or death.

Two hazards, one product line

The recall traces back to a problem with the hand-control pendants that patients and caregivers use to raise, lower and reposition the beds. According to the FDA's public notice, the pendant and its wiring can overheat in certain conditions — including when the bed is operated above its weight limit, when its movement is obstructed, or when a motor or component jams — and that overheating "may... pose a risk of fire." The agency's notice says Medline had logged 12 injuries and one death tied to the overheating pendants, plus two further injuries and a second death linked to a separate hazard: patients becoming trapped when non-Medline rails or accessories are attached to the beds. The FDA's own language on that second risk is blunt.

Entrapment could lead to asphyxiation, serious injury, and death.

Medline first flagged the pendant problem to customers on November 26, 2025, then expanded the correction to additional bed models on August 14, 2026. The FDA formally posted the matter as a Class I device recall on October 1, with a companion recall notice covering Medlite-branded beds sold under a related model line. Together, the agency's records say, 771,127 units reached the market — distributed across the United States, including Puerto Rico and Guam, and exported to Bermuda, Canada and Panama. The FDA attributes the cause to the device's design. Both recall records show they were updated on October 30, underscoring that the matter remains open as providers work through the list of affected beds.

From a warning label to a full withdrawal

What began as an instructions update escalated sharply this month. Rather than limit the fix to replacing pendants or revising labels, Medline's October 14 notice told providers to pull every Medline-branded bed from active use, regardless of which hazard applied to a given unit. The company's guidance, relayed by the long-term-care trade group, told facilities and home-care agencies to:

• Immediately unplug affected beds and disconnect any battery packs
• Stop using the bed's electrical functions, operating it in manual mode with a mattress in place until it is replaced
• Reserve electrical adjustments for emergencies such as choking or CPR, and avoid extension cords
• Stop using all bed accessories, including side rails, on Medline-brand beds
• Contact the provider or distributor that supplied the bed about repair, credit or reimbursement

On October 26, Medline revised those instructions again, this time "in consultation with" the FDA, according to a report by the trade publication HME News, which tracked the update on October 26. The revision allows patients to keep using covered beds under the tightened safety rules until a unit is repaired or replaced, rather than requiring every bed to be taken out of service immediately. Customers who bought a bed within the past five years are now eligible for repair, replacement or a full or partial refund; older units remain subject to the same restrictions but may not qualify for compensation. Medline says it will contact customers individually to determine eligibility and will mail safety labels to affected households; anyone who has not received one through their provider by November 30 is directed to call the company's recall line.

Who is affected

The beds covered by the recall are not hospital-ward equipment bought by health systems in bulk; they are the kind of adjustable beds that insurers and durable-medical-equipment suppliers place directly in patients' homes, typically for people receiving hospice care, recovering from major surgery, or living with conditions that limit their mobility. That makes the practical burden of the recall unusually diffuse: rather than a hospital swapping out a few units in a single building, it falls on individual patients, family caregivers and the home-care agencies and equipment dealers who serve them to identify affected beds, arrange for repairs or replacements, and in the meantime operate beds manually — a significant change in routine for people who may depend on electric positioning for comfort or safety.

It is also not the first time in recent years that a Medline home-care product has drawn a serious federal recall. In May 2024, the Consumer Product Safety Commission announced a separate recall of roughly 1.5 million Medline bed-assist rails after entrapment deaths in Iowa in 2019 and South Carolina in 2023. The current bed recall involves a different product line and a different regulator, but it points to a recurring hazard — entrapment and electrical failure in home medical equipment — that oversight agencies have flagged at the company more than once.

What happens next

For now, the recall remains open and unresolved for many of the roughly three-quarters of a million beds in circulation. The FDA has not set a public deadline for Medline to complete repairs or replacements, and the agency's recall listings note that correction and removal efforts are still underway. Patients, caregivers and facility staff who notice a hot pendant, smoke, sparking, or any sign of a stalled motor are instructed to unplug the bed immediately and call Medline's recall service rather than wait for a scheduled repair visit. Adverse events can also be filed directly with the FDA through its MedWatch safety reporting system, which keeps an independent record separate from the manufacturer's own count. With the recall still active and the company continuing to revise its guidance as recently as late October, providers that rely on Medline equipment are likely to spend weeks sorting out which beds qualify for free repair, which qualify for a refund, and which patients need an alternative bed in the meantime.